HK1130062A1 - - Google Patents

Info

Publication number: HK1130062A1
Authority: HK; Hong Kong

Application number

HK09110028.6A

Inventor

Heinz Fretz

Julien Pothier

Philippe Risch

Original Assignee

Actelion Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-07

Filing date

2009-10-28

Publication date

2009-12-18

2009-10-28 Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd

2009-12-18 Publication of HK1130062A1 publication Critical patent/HK1130062A1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Immunology (AREA)
Cardiology (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Pain & Pain Management (AREA)
Vascular Medicine (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

HK09110028.6A 2006-08-07 2009-10-28 HK1130062A1 (xx)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IB2006052723		2006-08-07
PCT/IB2007/053046 WO2008017989A1 (en)	2006-08-07	2007-08-02	(3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives

Publications (1)

Publication Number	Publication Date
HK1130062A1 true HK1130062A1 (xx)	2009-12-18

Family

ID=38805811

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK09110028.6A HK1130062A1 (xx)	2006-08-07	2009-10-28

Country Status (28)

Country	Link
US (1)	US8143304B2 (xx)
EP (2)	EP2051962B1 (xx)
JP (1)	JP5220013B2 (xx)
KR (1)	KR101411820B1 (xx)
CN (1)	CN101500996B (xx)
AR (1)	AR062222A1 (xx)
AT (1)	ATE530523T1 (xx)
AU (1)	AU2007282949B8 (xx)
BR (1)	BRPI0715179A2 (xx)
CA (1)	CA2658986C (xx)
CL (1)	CL2007002274A1 (xx)
CY (1)	CY1112276T1 (xx)
DK (1)	DK2051962T3 (xx)
ES (1)	ES2374321T3 (xx)
HK (1)	HK1130062A1 (xx)
HR (1)	HRP20120044T1 (xx)
IL (1)	IL196891A (xx)
MA (1)	MA30696B1 (xx)
MX (1)	MX2009001105A (xx)
MY (1)	MY147588A (xx)
NO (1)	NO20090979L (xx)
NZ (1)	NZ574705A (xx)
PL (1)	PL2051962T3 (xx)
PT (1)	PT2051962E (xx)
RU (1)	RU2448092C2 (xx)
SI (1)	SI2051962T1 (xx)
TW (1)	TWI408126B (xx)
WO (1)	WO2008017989A1 (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2558509C (en)	2004-03-11	2011-11-22	Actelion Pharmaceuticals Ltd	Tetrahydropyridoindole derivatives
CA2594280C (en)	2004-12-27	2013-04-23	Anja Fecher	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
NZ587709A (en)	2008-02-01	2012-06-29	Panmira Pharmaceuticals Llc	N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
JP2011513242A (ja)	2008-02-25	2011-04-28	アミラファーマシューティカルズ，インク．	プロスタグランジンｄ２受容体アンタゴニスト
EP2300425A4 (en) *	2008-06-24	2012-03-21	Panmira Pharmaceuticals Llc	PROSTAGLANDIN D2 RECEPTOR CYCLOALCANEÝBINDLUCK ANTAGONISTS
GB2463788B (en)	2008-09-29	2010-12-15	Amira Pharmaceuticals Inc	Heteroaryl antagonists of prostaglandin D2 receptors
WO2010042652A2 (en)	2008-10-08	2010-04-15	Amira Pharmaceuticals, Inc.	Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors
GB2465062B (en) *	2008-11-06	2011-04-13	Amira Pharmaceuticals Inc	Cycloalkane(B)azaindole antagonists of prostaglandin D2 receptors
JP4989786B1 (ja)	2009-02-24	2012-08-01	メルク・シャープ・エンド・ドーム・コーポレイション	Ｃｒｔｈ２受容体アンタゴニストとしてのインドール誘導体
WO2011014587A2 (en)	2009-07-31	2011-02-03	Amira Pharmaceuticals, Inc.	Ophthalmic pharmaceutical compositions of dp2 receptor antagonists
EP2462110A4 (en)	2009-08-05	2013-04-03	Panmira Pharmaceuticals Llc	DP2 ANTAGONIST AND USES THEREOF
CA2790139C (en) *	2010-03-22	2018-03-13	Actelion Pharmaceuticals Ltd	3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
EP2457900A1 (en)	2010-11-25	2012-05-30	Almirall, S.A.	New pyrazole derivatives having CRTh2 antagonistic behaviour
DK2697223T3 (en) *	2011-04-14	2016-09-05	Actelion Pharmaceuticals Ltd	7- (heteroaryl-amino) -6,7,8,9-tetrahydro-pyrido [1,2-a] indole-acetic acid derivatives and their use as prostaglandin D2 receptor
PL3119779T3 (pl)	2014-03-17	2019-01-31	Idorsia Pharmaceuticals Ltd	Pochodne kwasu azaindolooctowego i ich zastosowanie jako modulatorów receptora prostaglandyny d2
BR112016021443A8 (pt)	2014-03-18	2017-12-26	Actelion Pharmaceuticals Ltd	Derivados de ácido acético azaindol e seu uso como moduladores de receptor de prostaglandina d2
CN104402798B (zh) *	2014-10-21	2016-09-14	杭州瑞德化工有限公司	一种3-氨基-1，2，3，4-四氢咔唑的拆分方法
WO2016133793A1 (en)	2015-02-16	2016-08-25	Merck Sharp & Dohme Corp.	FACTOR IXa INHIBITORS
MX2018003202A (es)	2015-09-15	2018-06-08	Idorsia Pharmaceuticals Ltd	Formas cristalinas.
CN112094223B (zh) *	2019-06-18	2023-09-15	华东师范大学	一类脲基四氢咔唑类小分子有机化合物及用途

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4808608A (en) *	1986-01-23	1989-02-28	Merck & Co., Inc.	Tetrahydrocarbazole 1-alkanoic acids, pharmaceutical compositions and use
DE3631824A1 (de)	1986-02-21	1988-03-31	Bayer Ag	Cycloalkano(1.2-b)indol-sulfonamide
US4988820A (en) *	1986-02-21	1991-01-29	Bayer Aktiengesellschaft	Cycloalkano(1,2-B) indole-sulponamides
US5298626A (en) *	1991-01-18	1994-03-29	Hoechst-Roussel Pharmaceuticals Incorporated	Select cyclopent[b]indoles
GB9113802D0 (en) *	1991-06-26	1991-08-14	Smithkline Beecham Plc	Medicaments
US5350762A (en) *	1993-03-08	1994-09-27	Hoechst-Roussel Pharmaceuticals Incorporated	Tetrahydrocyclopent[B]indole methanamines and related compounds
WO2000063171A1 (fr) *	1999-04-20	2000-10-26	Meiji Seika Kaisha, Ltd.	Composes tricycliques
US20010047027A1 (en)	2000-04-12	2001-11-29	Marc Labelle	Prostaglandin D2 receptor antagonists
WO2002094830A2 (en)	2001-05-23	2002-11-28	Merck Frosst Canada & Co.	DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
GB2408001B (en)	2001-10-18	2006-03-29	Derek Colin Tolley	Filtration of liquid media
BR0214958A (pt) *	2001-12-14	2004-12-28	Zentaris Gmbh	Derivados de tetraidrocarbazol como ligandos para receptores acoplados à proteìna-g (gpcr)
AR038136A1 (es)	2002-01-24	2004-12-29	Merck Frosst Canada Inc	Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
SE0200411D0 (sv)	2002-02-05	2002-02-05	Astrazeneca Ab	Novel use
SE0200356D0 (sv)	2002-02-05	2002-02-05	Astrazeneca Ab	Novel use
US7534897B2 (en) *	2002-05-16	2009-05-19	Shionogi & Co., Ltd.	Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism
JPWO2003097042A1 (ja)	2002-05-16	2005-09-15	塩野義製薬株式会社	Ｐｇｄ２受容体拮抗剤
GB2388540A (en)	2002-05-17	2003-11-19	Bayer Ag	New use of Ramatroban
SE0201635D0 (sv)	2002-05-30	2002-05-30	Astrazeneca Ab	Novel compounds
TW200307542A (en)	2002-05-30	2003-12-16	Astrazeneca Ab	Novel compounds
SE0202241D0 (sv)	2002-07-17	2002-07-17	Astrazeneca Ab	Novel Compounds
EP1558614B1 (en)	2002-10-30	2010-09-01	Merck Frosst Canada Ltd.	Pyridopyrrolizine and pyridoindolizine derivatives
JPWO2004078719A1 (ja)	2003-03-06	2006-06-08	小野薬品工業株式会社	インドール誘導体化合物およびその化合物を有効成分とする薬剤
CA2526013A1 (en)	2003-05-20	2004-12-02	Merck Frosst Canada Ltd.	Fluoro-methanesulfonyl-substituted cycloalkanoindoles and their use as prostaglandin d2 antagonists
SE0301569D0 (sv)	2003-05-27	2003-05-27	Astrazeneca Ab	Novel compounds
EP1638967A2 (en)	2003-06-12	2006-03-29	Merck Frosst Canada Ltd.	Cycloalkanepyrrolopyridines as dp receptor antagonists
SE0302232D0 (sv)	2003-08-18	2003-08-18	Astrazeneca Ab	Novel Compounds
WO2005033099A2 (en)	2003-10-03	2005-04-14	Glenmark Pharmaceuticals Ltd.	Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof
US20070232681A1 (en)	2003-10-14	2007-10-04	Oxagen Limited	Compounds Having Crth2 Antagonist Activity
WO2005040112A1 (en)	2003-10-14	2005-05-06	Oxagen Limited	Compounds with pgd2 antagonist activity
GB2407318A (en)	2003-10-23	2005-04-27	Oxagen Ltd	Substituted Indol-3-yl acetic acid derivatives
GB0324763D0 (en)	2003-10-23	2003-11-26	Oxagen Ltd	Use of compounds in therapy
SE0303180D0 (sv)	2003-11-26	2003-11-26	Astrazeneca Ab	Novel compounds
US7019022B2 (en)	2003-12-15	2006-03-28	Merck Frosst Canada & Co.	Substituted tetrahydrocarbazole and cyclopentanoindole derivatives
US7750014B2 (en)	2004-01-31	2010-07-06	Actimis Pharmaceuticals, Inc.	Imidazo[1,2-C]pyrimidinylacetic acid derivatives
CA2558509C (en)	2004-03-11	2011-11-22	Actelion Pharmaceuticals Ltd	Tetrahydropyridoindole derivatives
AU2005229522A1 (en) *	2004-03-11	2005-10-13	Actelion Pharmaceuticals Ltd.	Indol-1-yl-acetic acid derivatives
US20050234030A1 (en)	2004-04-20	2005-10-20	Wilmin Bartolini	Modulators of CRTH2, COX-2 and FAAH
GB0412914D0 (en)	2004-06-10	2004-07-14	Oxagen Ltd	Compounds
MY144903A (en)	2004-06-17	2011-11-30	Novartis Ag	Pyrrolopyridine derivatives and their use as crth2 antagonists
MX2007002126A (es)	2004-08-26	2007-09-14	Actelion Pharmaceuticals Ltd	Derivados de acido 2-sulfanil-benzoimidazol-1-il-acetico como antagonistas de crth 2.
US7732618B2 (en)	2004-09-21	2010-06-08	Wyeth	Benzimidazole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof
EP1805171A4 (en)	2004-09-21	2009-05-13	Wyeth Corp	CRTH2 RECEPTOR ANTAGONISM DISPLAYING INDIGENOUS ACIDS AND APPLICATIONS THEREOF
CA2594280C (en) *	2004-12-27	2013-04-23	Anja Fecher	2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
DOP2006000016A (es)	2005-01-26	2006-07-31	Aventis Pharma Inc	2-fenil-indoles como antagonistas del receptor de la prostaglandina d2.
GB2422829A (en)	2005-02-04	2006-08-09	Oxagen Ltd	Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
GB2422831A (en)	2005-02-04	2006-08-09	Oxagen Ltd	Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
GB2422830A (en)	2005-02-04	2006-08-09	Oxagen Ltd	Pyrrolopyridines and their use in the treatment of diseases mediated by PGD2 at the CRTH2 receptor
WO2006090817A1 (ja)	2005-02-25	2006-08-31	Ono Pharmaceutical Co., Ltd.	インドール化合物およびその用途
GB0504150D0 (en)	2005-03-01	2005-04-06	Oxagen Ltd	Microcrystalline material
GB0505048D0 (en)	2005-03-11	2005-04-20	Oxagen Ltd	Compounds with PGD antagonist activity
ES2375614T3 (es)	2005-05-24	2012-03-02	Merck Serono Sa	Derivados de espiro tric�?clicos como moduladores de crth2
GB0512944D0 (en)	2005-06-24	2005-08-03	Argenta Discovery Ltd	Indolizine compounds
EP1916245B1 (en)	2005-07-22	2011-10-26	Shionogi & Co., Ltd.	Indole derivative having pgd2 receptor antagonist activity
WO2007010965A1 (ja)	2005-07-22	2007-01-25	Shionogi & Co., Ltd.	Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体
EP1915372B1 (en)	2005-08-12	2013-11-20	Merck Canada Inc.	Indole derivatives as crth2 receptor antagonists
EP1931632A4 (en)	2005-08-18	2011-05-11	Microbia Inc	USEFUL INDOOR CONNECTIONS
WO2007029629A1 (ja)	2005-09-06	2007-03-15	Shionogi & Co., Ltd.	Ｐｇｄ２受容体アンタゴニスト活性を有するインドールカルボン酸誘導体
GB0518783D0 (en)	2005-09-14	2005-10-26	Argenta Discovery Ltd	Indolizine compounds
GB0521275D0 (en)	2005-10-19	2005-11-30	Argenta Discovery Ltd	3-Aminoindole compounds
GB0525141D0 (en)	2005-12-09	2006-01-18	Novartis Ag	Organic compounds
GB0525144D0 (en)	2005-12-09	2006-01-18	Novartis Ag	Organic compounds
GB0525143D0 (en)	2005-12-09	2006-01-18	Novartis Ag	Organic compounds
GB0525337D0 (en)	2005-12-13	2006-01-18	Novartis Ag	Organic compounds

2007
- 2007-08-02 DK DK07805287.5T patent/DK2051962T3/da active
- 2007-08-02 EP EP07805287A patent/EP2051962B1/en active Active
- 2007-08-02 CN CN2007800292169A patent/CN101500996B/zh not_active Expired - Fee Related
- 2007-08-02 EP EP11000641A patent/EP2316824A1/en not_active Withdrawn
- 2007-08-02 RU RU2009107889/04A patent/RU2448092C2/ru not_active IP Right Cessation
- 2007-08-02 US US12/376,932 patent/US8143304B2/en not_active Expired - Fee Related
- 2007-08-02 MX MX2009001105A patent/MX2009001105A/es active IP Right Grant
- 2007-08-02 AU AU2007282949A patent/AU2007282949B8/en not_active Ceased
- 2007-08-02 PL PL07805287T patent/PL2051962T3/pl unknown
- 2007-08-02 JP JP2009523396A patent/JP5220013B2/ja not_active Expired - Fee Related
- 2007-08-02 AT AT07805287T patent/ATE530523T1/de active
- 2007-08-02 MY MYPI20090462A patent/MY147588A/en unknown
- 2007-08-02 SI SI200730818T patent/SI2051962T1/sl unknown
- 2007-08-02 PT PT07805287T patent/PT2051962E/pt unknown
- 2007-08-02 BR BRPI0715179-9A patent/BRPI0715179A2/pt not_active IP Right Cessation
- 2007-08-02 NZ NZ574705A patent/NZ574705A/en not_active IP Right Cessation
- 2007-08-02 ES ES07805287T patent/ES2374321T3/es active Active
- 2007-08-02 KR KR1020097004370A patent/KR101411820B1/ko active IP Right Grant
- 2007-08-02 WO PCT/IB2007/053046 patent/WO2008017989A1/en active Application Filing
- 2007-08-02 CA CA2658986A patent/CA2658986C/en not_active Expired - Fee Related
- 2007-08-06 CL CL200702274A patent/CL2007002274A1/es unknown
- 2007-08-06 TW TW096128871A patent/TWI408126B/zh not_active IP Right Cessation
- 2007-08-06 AR ARP070103462A patent/AR062222A1/es unknown
2009
- 2009-02-04 IL IL196891A patent/IL196891A/en not_active IP Right Cessation
- 2009-02-17 MA MA31646A patent/MA30696B1/fr unknown
- 2009-03-04 NO NO20090979A patent/NO20090979L/no not_active Application Discontinuation
- 2009-10-28 HK HK09110028.6A patent/HK1130062A1/xx not_active IP Right Cessation
2012
- 2012-01-13 HR HR20120044T patent/HRP20120044T1/hr unknown
- 2012-01-25 CY CY20121100090T patent/CY1112276T1/el unknown

Also Published As

Publication number	Publication date
RU2009107889A (ru)	2010-09-20
PL2051962T3 (pl)	2012-03-30
US8143304B2 (en)	2012-03-27
MY147588A (en)	2012-12-31
IL196891A0 (en)	2009-11-18
DK2051962T3 (da)	2012-01-02
PT2051962E (pt)	2012-01-10
KR101411820B1 (ko)	2014-06-24
CY1112276T1 (el)	2015-12-09
EP2051962B1 (en)	2011-10-26
WO2008017989A1 (en)	2008-02-14
SI2051962T1 (sl)	2012-02-29
CA2658986C (en)	2014-11-25
JP5220013B2 (ja)	2013-06-26
NZ574705A (en)	2011-12-22
ATE530523T1 (de)	2011-11-15
CN101500996A (zh)	2009-08-05
AU2007282949A1 (en)	2008-02-14
TWI408126B (zh)	2013-09-11
EP2051962A1 (en)	2009-04-29
CA2658986A1 (en)	2008-02-14
RU2448092C2 (ru)	2012-04-20
AU2007282949B8 (en)	2012-10-04
US20100190830A1 (en)	2010-07-29
MX2009001105A (es)	2009-02-10
JP2010500337A (ja)	2010-01-07
CL2007002274A1 (es)	2008-04-18
IL196891A (en)	2013-07-31
AR062222A1 (es)	2008-10-22
CN101500996B (zh)	2012-07-04
ES2374321T3 (es)	2012-02-15
KR20090047504A (ko)	2009-05-12
HRP20120044T1 (hr)	2012-02-29
NO20090979L (no)	2009-05-06
BRPI0715179A2 (pt)	2013-06-11
AU2007282949B2 (en)	2012-08-30
MA30696B1 (fr)	2009-09-01
TW200817328A (en)	2008-04-16
EP2316824A1 (en)	2011-05-04

Publication	Publication Date	Title
BRPI0720064A2 (xx)	2017-08-15
BRMU8603216U8 (xx)	2012-10-16
BRPI0715824A8 (xx)	2008-02-28
BRPI0713487A2 (xx)	2012-11-13
BR122016023444A2 (xx)	2008-01-15
BRPI0708307B8 (xx)	2021-05-25
CH2121272H1 (xx)	2020-12-15
BY9789C1 (xx)	2007-10-30
CN300725931S (zh)	2008-01-02	童装(3815)
CN300725924S (zh)	2008-01-02	童装(3789)
CN300725944S (zh)	2008-01-02	童装(3890)
CN300725943S (zh)	2008-01-02	童装(3876)
CN300725942S (zh)	2008-01-02	童装(3874)
CN300725941S (zh)	2008-01-02	童装(3872)
CN300725940S (zh)	2008-01-02	童装(3870)
CN300725939S (zh)	2008-01-02	童装裤子(3856)
CN300725930S (zh)	2008-01-02	童装(3813)
CN300725912S (zh)	2008-01-02	童装(3706)
CN300725913S (zh)	2008-01-02	童装(3712)
CN300725914S (zh)	2008-01-02	童装(3714)
CN300725915S (zh)	2008-01-02	童装(3728)
CN300725916S (zh)	2008-01-02	童装(3732)
CN300725917S (zh)	2008-01-02	童装(3734)
CN300725918S (zh)	2008-01-02	童装(3748)
CN300725919S (zh)	2008-01-02	童装(3752)

Legal Events

Date	Code	Title	Description
2017-03-03	PC	Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)	Effective date: 20160802